Literature DB >> 19048246

Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus.

R Antonucci1, L Cuzzolin, A Arceri, A Dessì, V Fanos.   

Abstract

PURPOSE: To investigate changes in urinary PGE(2) after ibuprofen treatment in preterm infants with patent ductus arteriosus (PDA).
METHODS: Twenty preterm infants with a hemodynamically significant PDA (gestational age, 28.6 +/- 2.3 weeks) and 20 controls (gestational age, 30.4 +/- 1.5 weeks) were prospectively enrolled at 48-72 h of life. After enrollment, the former underwent conventional ibuprofen-lysine treatment. At 48-72 h (T(0)) and 108-144 h of life (T(1)), urine samples were noninvasively collected in both groups to measure urinary PGE(2) concentrations (enzyme immunoassay method), and renal function was investigated.
RESULTS: Urinary PGE(2) decreased significantly both in ibuprofen-treated patients (66.95 +/- 16.78 vs. 27.15 +/- 17.92 pg/mL, P < 0.001) and in controls (71.7 +/- 16.2 vs. 53.2 +/- 18.4 pg/mL, P < 0.001) from T(0) to T(1). However, urinary PGE(2) at T(1) was significantly lower (P < 0.001) in the ibuprofen group compared to the control group. Acute renal failure occurred in three ibuprofen-treated patients (15%).
CONCLUSIONS: Ibuprofen markedly reduces (59.4%) urinary PGE(2) and may alter renal function in the newborn.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19048246     DOI: 10.1007/s00228-008-0586-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  36 in total

1.  Ibuprofen as effective as indomethacin for patent ductus arteriosus.

Authors:  R SoRelle
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

2.  Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants.

Authors:  Maria M Rodríguez; Alexander H Gómez; Carolyn L Abitbol; Jayanthi J Chandar; Shahnaz Duara; Gastón E Zilleruelo
Journal:  Pediatr Dev Pathol       Date:  2004 Jan-Feb

Review 3.  A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus.

Authors:  Ronald L Thomas; Graham C Parker; Bart Van Overmeire; Jacob V Aranda
Journal:  Eur J Pediatr       Date:  2004-12-10       Impact factor: 3.183

Review 4.  Renal arachidonic acid metabolism.

Authors:  M G Currie; P Needleman
Journal:  Annu Rev Physiol       Date:  1984       Impact factor: 19.318

5.  A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.

Authors:  B Van Overmeire; K Smets; D Lecoutere; H Van de Broek; J Weyler; K Degroote; J P Langhendries
Journal:  N Engl J Med       Date:  2000-09-07       Impact factor: 91.245

Review 6.  NSAID-induced nephrotoxicity from the fetus to the child.

Authors:  L Cuzzolin; M Dal Cerè; V Fanos
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.606

Review 7.  Renal effects of ibuprofen for the treatment of patent ductus arteriosus in premature infants.

Authors:  R P Giniger; C Buffat; V Millet; U Simeoni
Journal:  J Matern Fetal Neonatal Med       Date:  2007-04

8.  Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.

Authors:  Eli Heyman; Iris Morag; David Batash; Rimona Keidar; Shaul Baram; Matitiahu Berkovitch
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

9.  Urinary prostaglandin E2 in patients with vesicoureteral reflux.

Authors:  R D Walker; E H Garin
Journal:  Child Nephrol Urol       Date:  1990

Review 10.  Urinary prostaglandin E2 in the newborn and infant.

Authors:  Roberto Antonucci; Laura Cuzzolin; Augusta Arceri; Vassilios Fanos
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-05-06       Impact factor: 3.072

View more
  8 in total

1.  Neonatal pharmacology: extensive interindividual variability despite limited size.

Authors:  Cuneyt Tayman; Maisa Rayyan; Karel Allegaert
Journal:  J Pediatr Pharmacol Ther       Date:  2011-07

2.  Ibuprofen in very preterm infants impairs renal function for the first month of life.

Authors:  Rachel Vieux; Roxane Desandes; Farid Boubred; Denis Semama; Francis Guillemin; Marie-Christine Buchweiller; Jeanne Fresson; Jean-Michel Hascoet
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

3.  Patent ductus arteriosus is associated with acute kidney injury in the preterm infant.

Authors:  Batoule Majed; David A Bateman; Natalie Uy; Fangming Lin
Journal:  Pediatr Nephrol       Date:  2019-01-31       Impact factor: 3.714

Review 4.  Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?

Authors:  Vassilios Fanos; Michele Pusceddu; Angelica Dessì; Maria Antonietta Marcialis
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 5.  Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs in Neonates.

Authors:  Karel Allegaert; Jan De Hoon; Anne Debeer; Marc Gewillig
Journal:  Pharmaceuticals (Basel)       Date:  2010-02-03

Review 6.  Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?

Authors:  Flaminia Bardanzellu; Paola Neroni; Angelica Dessì; Vassilios Fanos
Journal:  Biomed Res Int       Date:  2017-07-30       Impact factor: 3.411

Review 7.  Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Moreyba Borges-Lujan; Gema E Gonzalez-Luis; Tom Roosen; Maurice J Huizing; Eduardo Villamor
Journal:  J Pers Med       Date:  2022-07-14

8.  Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial.

Authors:  Bo Yang; Xiangyu Gao; Yi Ren; Yun Wang; Qinglin Zhang
Journal:  Exp Ther Med       Date:  2016-09-06       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.